How to buy Intercure stock

Israeli cannabis producer Intercure has applied to have its stock listed on the Nasdaq. The stock is currently listed on the Toronto Stock Exchange under the ticker symbol "INCR:U" and on the Tel Aviv Stock Exchange under the ticker symbol "INCR." If accepted, the stock will trade on the Nasdaq under the same symbol.

We'll update this page as new information becomes available.

Intercure stock price (NASDAQ: INCR)

Use our graph to track the performance of INCR stocks over time.

Intercure shares at a glance

• Key figures

Information last updated 2023-01-31.

Latest market close	$3.72
52-week range	$3.27 - $8.20
50-day moving average more info button	$4.22
200-day moving average more info button	$5.26
Wall St. target price	$33.70
PE ratio more info button	16.3636
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$0.22

Buy Intercure stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Intercure stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Intercure price performance over time

Historical closes compared with the close of $3.72 from 2023-02-01

1 week (2023-01-26)	-0.53%
1 month (2022-12-30)	12.73%
3 months (2022-11-02)	-24.24%
6 months (2022-08-02)	-39.61%

1 year (2022-02-02)	-41.97%
2 years (2021-02-02)	118.82%
3 years (2020-01-30)	200.00%
5 years (2018-01-29)	N/A

Is Intercure stock undervalued or overvalued?

Valuing Intercure stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Intercure's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Intercure's P/E ratio

Intercure's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Intercure shares trade at around 16x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Intercure's P/E ratio is best considered in relation to those of others within the drug manufacturers-specialty & generic industry or those of similar companies.

• Tilray (TLRY.US): 7.71

Intercure financials

Gross profit TTM	$102.6 million
Return on assets TTM	5.38%
Return on equity TTM	7.36%
Profit margin	9.15%
Book value	N/A
Market capitalisation more info button	$164.1 million

TTM: trailing 12 months

Intercure share dividends

We're not expecting Intercure to pay a dividend over the next 12 months.

Have Intercure's shares ever split?

Intercure's shares were split on a 946:4209 basis on 8 April 2021. So if you had owned 4209 shares the day before before the split, the next day you'd have owned 946 shares. This wouldn't directly have changed the overall worth of your Intercure shares – just the quantity. However, indirectly, the new 344.9% higher share price could have impacted the market appetite for Intercure shares which in turn could have impacted Intercure's share price.

Intercure share price volatility

Over the last 12 months, Intercure's shares have ranged in value from as little as $3.27 up to $8.2. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intercure's is -0.2095. This would suggest that Intercure's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Intercure has bucked the trend.

To put Intercure's beta into context you can compare it against those of similar companies.

• Tilray (TLRY.US): 2.6198
• Canopy Growth (CGC.US): 2.1729
• Cronos Group (CRON.US): 1.3739

Intercure overview

InterCure Ltd. , together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel. .

Frequently asked questions

What percentage of Intercure is owned by insiders or institutions?
Currently 37.636% of Intercure shares are held by insiders and 11.507% by institutions. How many people work for Intercure?
Latest data suggests 350 work at Intercure. When does the fiscal year end for Intercure?
Intercure's fiscal year ends in December. Where is Intercure based?
Intercure's address is: 85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670 What is Intercure's ISIN number?
Intercure's international securities identification number is: IL0011063760